Egidio Nascimento
Nessuna posizione attualmente
Profilo
Egidio Nascimento worked as a Director at Génome Québec, Inc. and Innovative Materials Technologies, Inc. He was also a Senior Manager at KPMG, Inc. (Ontario).
He served as the Chief Financial Officer at Variation Biotechnologies (US), Inc., Genome Canada, and VBI Vaccines, Inc. Additionally, he was the Group Financial Controller at VBI Vaccines, Inc. from 2014 to 2016.
Mr. Nascimento obtained an undergraduate degree from the University of Ottawa.
Precedenti posizioni note di Egidio Nascimento
Società | Posizione | Fine |
---|---|---|
VBI VACCINES INC | Director of Finance/CFO | - |
VBI VACCINES INC. | Director of Finance/CFO | - |
KPMG, Inc. (Ontario)
KPMG, Inc. (Ontario) Miscellaneous Commercial ServicesCommercial Services KPMG, Inc. provides management consulting services. The company is headquartered in Toronto, Canada. | Corporate Officer/Principal | - |
Génome Québec, Inc.
Génome Québec, Inc. Miscellaneous Commercial ServicesCommercial Services Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada. | Director/Board Member | - |
Innovative Materials Technologies, Inc.
Innovative Materials Technologies, Inc. Other TransportationTransportation Innovative Materials Technologies, Inc. was provided surface protection technologies and materials. The company was headquartered in Gatineau, Canada. | Director/Board Member | - |
Formazione di Egidio Nascimento
University of Ottawa | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
VBI VACCINES INC. | Health Technology |
Aziende private | 6 |
---|---|
Variation Biotechnologies (US), Inc.
Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Variation Biotechnologies (US), Inc. develops and manufactures vaccines for infectious diseases. It is dedicated to the innovative formulation, development and delivery of safe and effective vaccines that expand and enhance vaccine protection in both established and emerging markets. The company was founded by David E. Anderson and Adam Buckley in 2001 and is headquartered in Boston, MA. | Health Technology |
Genome Canada
Genome Canada Miscellaneous Commercial ServicesCommercial Services Genome Canada provides genomic research services. It connects ideas and people across public and private sectors to find new uses for genomics, invests in large-scale science and technology to fuel innovation,and translates discoveries into applications, new technologies, societal impacts and solutions across key sectors of national importance, including health, agriculture, forestry, fisheries and aquaculture, energy, mining, and the environment. The company was founded in 2000 and is headquartered in Ottawa, Canada. | Commercial Services |
Génome Québec, Inc.
Génome Québec, Inc. Miscellaneous Commercial ServicesCommercial Services Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada. | Commercial Services |
KPMG, Inc. (Ontario)
KPMG, Inc. (Ontario) Miscellaneous Commercial ServicesCommercial Services KPMG, Inc. provides management consulting services. The company is headquartered in Toronto, Canada. | Commercial Services |
Innovative Materials Technologies, Inc.
Innovative Materials Technologies, Inc. Other TransportationTransportation Innovative Materials Technologies, Inc. was provided surface protection technologies and materials. The company was headquartered in Gatineau, Canada. | Transportation |
VBI Vaccines, Inc. /Old/
VBI Vaccines, Inc. /Old/ BiotechnologyHealth Technology VBI Vaccines, Inc. is a biopharmaceutical company. It engages in the development of eVLP vaccine platform for the design of (e) virus-like-particle vaccines that closely mimic the target virus. The company also involves in the development of thermostable technology that enables the development of vaccines and biologics that can withstand storage or shipment at constantly fluctuating temperatures. VBI Vaccines was founded on July 25, 2014 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Egidio Nascimento